To the Editor—We read with great interest the recent article by Tamma et al [1], who reported that patients with carbapenemase-producing carbapenem-resistant Enterobacteriaceae (CP-CRE) have 2.6 and 4.9 higher odds for bacteremia recurrence at 30 days and mortality at 14 days, respectively, compared with patients with non-CP CRE.
from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2fXQvjV
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,